Ru Back Packer

Quotes delayed 20 minutes



If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Free Preferred Stock Newsletter
Gain access to weekly reports with featured preferred stock screens, new preferred stock offerings, and more.

Slideshow Preferred Stocks By Industry: Drugs & Pharmaceuticals

By Ru Back Packer Staff, updated Tuesday, January 23, 11:07 AM

#1. Cyclacel Pharmaceuticals Inc | 6% Convertible Exchangeable Preferred Stock (NASDAQ:CYCCP)

Discount to Liquidation Preference: -41.50%
Current Annualized Yield: 10.26%
Days Since Last Ex-Div Date: 11 | See Dividend History »
Categorization: Drugs & Pharmaceuticals

Redeemable?:Yes
Call Date:11/6/2007 (Now Trading Post Call Date)
Perpetual?:Yes
Cumulative?:Yes
Conversion Ratio:4.2553
Conversion Price:$2.35
Shares Offered:2600000
Overallotment:390000
Liquidation Preference:$10
Recent Market Price:$5.85
Discount to Liquidation Preference:
(More Preferreds Trading at a Discount »)
$-4.15 (-41.50%)
Annualized Dividend:0.6
Recent Ex-Date:1/11/2018
Current Yield:10.26%
Original Coupon:6.00%
Pay Period:Quarterly
Pay Dates:1-Feb, 1-May, 1-Aug, 1-Nov
Cyclacel Pharmaceuticals is a clinical-stage biopharmaceutical company using cell cycle, transcriptional regulation and deoxyribonucleic acid (DNA) damage response biology to develop medicines for cancer and other proliferative diseases. Co.'s transcriptional regulation program is evaluating CYC065, a cyclin dependent kinases (CDK) inhibitor, in patients with advanced cancers. The DNA damage response program is evaluating a sequential regimen of sapacitabine and seliciclib, a CDK inhibitor, in patients with BRCA positive, advanced solid cancers. Co. is also analyzing stratified and exploratory subgroups from a Phase 3 study of sapacitabine in elderly patients with acute myeloid leukemia.

Preferred: CYCCP


Open the CYCC Information Page »
Name: Cyclacel Pharmaceuticals Inc
Website: cyclacel.com
Sector: Drugs & Pharmaceuticals
Number of ETFs Holding CYCC: 1 (see which ones)
Total Market Value Held by ETFs: $1,400
Total Market Capitalization: $20,000,000
% of Market Cap. Held by ETFs: 0.01%

Top Ten Highest Yielding Preferred Stocks
Feel-Good Income: Socially Responsible Preferreds
Dividend Channel's 25 S.A.F.E. Dividend Stocks
Increasing Payments For Decades

Safer than S.A.F.E: Preferreds of Dividend Channel's
S.A.F.E. Dividend Stocks

Recent Preferred Stock Offerings
Preferred Stocks of Dow Components
Preferred Stocks of S&P 500 Components
Preferred Stocks By Industry
Preferred Stocks Where Insiders Are Buying The Common
High Yield Preferred Stocks
Preferreds Trading At Premiums To Liquidation Preference
Preferreds Trading At Discounts To Liquidation Preference

The Top 10 DividendRank'ed Canadian Stocks
Top 25 Broker Analyst Picks of the S&P 500

Preferred Stocks By Industry: Drugs & Pharmaceuticals - Slide 1 of 1 | rubackpacker.com | Copyright © 2011 - 2018, All Rights Reserved